Plasminogen activator (PA) is the enzyme that converts plasminogen to its active form, plasmin, which is involved in various physiological and pathological phenomena. The conversion is catalyzed by two types of PA, urokinase-type PA (uPA) and tissue-type PA (tPA). We investigated the effect of the inflammatory cytokine interleukin-1β (IL-1β) on PA secretion in human dental pulp cells. When the cells were stimulated by IL-1β, PA activity in the medium was clearly increased in a time-and dose-dependent manner. This PA activity in the medium was reduced after immunoprecipitation with anti-uPA antibody, and uPA protein was detected in the immunoprecipitated fraction by Western blotting. However, no such effect was observed with anti-tPA antibody. In the IL-1β-stimulated cells, expression of uPA mRNA was enhanced whereas expression of tPA mRNA was less. The IL-1β-stimulated uPA mRNA expression and PA activities in the cell lysate and medium were reduced by the tyrosine kinase inhibitors herbimycin A and genistein, and by the NFκB inhibitor pyrolidinedithiocarbamate, and were augmented by the tyrosine phosphatase inhibitor sodium orthovanadate. These observations suggest that IL-1β stimulates uPA production via activation of NFκB and tyrosine phosphorylation, and also secretion of the enzyme, and that the uPA/plasmin system appears to be involved in inflammation in human dental pulp.
Plasmin, a serine protease, is involved in the degradation of extracellular matrix and basement membranes, either directly or indirectly through activation of metalloproteinases and other zymogens (16, 28) . Plasmin is produced through conversion of plasminogen by plasminogen activators (PAs) (28) . Because PAs and their inhibitors are key participants in the balance between proteolytic and antiproteolytic activities, the plasminogen activating system is involved in a number of physiological and pathological phenomena, such as clotting, fibrinolysis, inflammation and tissue remodeling (26) . Two types of PAs, tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), are expressed by numerous tissues. These proteins are derived from distinct genes and show tissue-specific expression and biological activities (9) . tPA is a 70-kDa protein which is secreted as a precursor in a single chain form. This single chain form has a significant activity. The precursor is converted to the active two-chain form by cleavage by plasmin (9) . On the other hand, uPA is produced as a singlechain pro-uPA, a 53-kDa protein with low PA activity. Pro-uPA binds to a specific receptor (uPAR) on the surface of cells. Pro-uPA bound to its receptor is converted into enzymatically active uPA by proteases, such as plasmin, cathepsin B and plasma kallikrein (9) . tPA is primarily implicated in fibrinolysis because of its high affinity for fibrin and the extracellular matrix, whereas uPA promotes cell migra-antibody was purchased from Upstate (Lake Placid, NY).
Cell culture. Human dental pulp (fibroblast-like) cells were obtained from the extracted third molars under aseptic conditions from patients aged 20 years during orthodontic treatment. The patients gave informed consent before providing the samples. After the dental pulp had been extracted, the tissue was minced, placed on a 35-mm tissue culture dish, and covered with a sterilized glass coverslip. α-MEM supplemented with 10% FCS and antibiotics (100 μg/ mL penicillin G, 1 mg/mL kanamycin, 1 mg/mL fungizone) was used for culture. Once cell growth from the explants had reached confluence, the cells were detached with 0.05% trypsin in phosphatebuffered saline and subcultured in culture flasks. For the experiments, the cells from passages 6 to 9 were plated at 2 × 10 5 cells/mL medium. This study was approved by the ethics committee of Nihon University School of Dentistry at Matsudo (No. EC02-078).
PA assay. Cells (1 × 10 5 ) were plated on 35-mm tissue culture dishes. After the cells had reached confluence, they were incubated for 24 h in medium containing 1% FCS, and then treated with IL-1β. PA activity in the conditioned medium was measured in accordance with the method described previously (12) . A mixture of 12 μL plasminogen (0.75 mg/ mL), 12 μL CNBr fibrinogen (3.3 mg/mL) and 30 μL Tris-HCl buffer (10 mM, pH 7.4) was added to a sample tube, and H 2 O was added to a final volume of 90 μL. The assay was started by adding 30 μL of each sample and incubated at 37°C for 45 min. Then 35 μL of S2251 was added to the reaction mixture, and incubation was continued for a further 15 min. The reaction was stopped by adding 100 μL citric acid (20 mg/mL). Color development was followed at 415 nm in a microplate reader (MTP-300 Corona Electric, Japan).
RT-PCR.
Total cellular RNA was extracted from human dental pulp cells using an RNeasy mini kit (QIAGEN ® ). The procedure for isolation of RNA was in accordance with the protocol provided with the RNeasy mini kit. cDNA synthesis and amplification by RT-PCR were conducted using a One Step RT-PCR kit. For the PCR mixture, RNA (250 ng) and the following oligonucleotide primers (500 nM) were used: uPA primer, 5'-TTTGCGGCCATCTA CAGGAG-3' (forward) and 5'-ACTGGGGATCGT TATACATC-3' (reverse); tPA primer, 5'-CAGG AAATCCATGCCCGATT-3' (forward) and 5'-GCT tion and proliferation via interaction with highaffinity cell surface receptors (uPAR), suggesting that the two type of PAs have different biological roles (11, 13, 20) .
Dental pulp is a loosely formed mesenchymal tissue almost entirely enclosed within a mineralized tissue, dentin. Inflammation in the pulp is essentially the same as that occurring in connective tissue elsewhere in the body. Dental pulp infection is most commonly caused by extensive dental caries. It has been reported that elastinolytic and collagenolytic activities are increased in diseased human dental pulp with suppurative pulpitis and necrosis (19) . Inflammatory cytokines have been considered to play an important role in dental pulp inflammation, because levels of cytokine mRNAs are increased in inflamed dental pulp (33) . Furthermore, in dental pulp cells, it has been demonstrated that interleukin-1β (IL-1β) induces prostaglandin E 2 production via cyclooxygenase-2 mRNA expression, which is strongly related to inflammation (3), and that IL-1α and tumor necrosis factor-α stimulate the synthesis of mRNA for matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1, which are involved in the degradation of extracellular matrix in inflammatory diseases (15) .
To clarify the relationship between PAs and inflammation in dental pulp, we investigated the effect of IL-1β on expression of PAs in primary cultured human dental pulp cells. In this paper, we demonstrate that IL-1β induces uPA production and secretion in human dental pulp cells.
MATERIALS AND METHODS

Materials.
Fetal calf serum (FCS), α-minimal essential medium (α-MEM), fungizone and trypsin were obtained from GIBCO BRL Life Technologies (Tokyo, Japan). Penicillin G and kanamycin were from Meiji Seika (Tokyo, Japan). Herbimycin A and pyrolidine dithiocarbamate (PDTC) were from Seikagaku Corporation (Tokyo, Japan). Genistein was purchased from Wako Pure Chemical Industries (Tokyo, Japan). Sodium orthovanadate was from Sigma-Aldrich Japan (Tokyo, Japan). The cytokine IL-1β was obtained from TECHNE Corporation (Minneapolis, MN). PA assay agents, fluorescent substrate S2251, plasminogen and PA stimulator were obtained from Chromogenix (Milano, Italy). CNBr fibrinogen fragments were from American Diagnostica Inc. (Stamford, CT). Anti-uPA monoclonal antibody and uPA (human urine) were from Calbiochem (Darmstadt, Germany). Anti-tPA monoclonal tion of immunoreactivity.
Protein assay. Protein concentrations were determined by the method of Bradford (2) with bovine serum albumin as the standard.
Statistical analysis.
Results are presented as means ± SE for the number of experiments indicated. Tukey test was performed for statistical analysis.
RESULTS
IL-1β-stimulated PA secretion in human dental pulp cells
We first determined the effect of IL-1β on PA secretion by human dental pulp cells. When the cells were stimulated with 100 pg/mL IL-1β, PA activity in the conditioned medium was increased in a timedependent manner, as Fig. 1A shows. PA activity in the medium increased for 12 h before reaching a plateau level. Fig. 1B summarizes PA secretion from cells stimulated by IL-1β at concentrations of 10-250 pg/mL for 12 h. PA activity in the medium was increased with 10-50 pg/mL of IL-1β in a dose dependent manner.
IL-1β-stimulated uPA secretion
Two types of PAs, uPA and tPA, are known to exist. Therefore, we examined the type of PA secreted from IL-1β-stimulated human dental pulp cells. Af-GATGAGTATGCCCCCGCACAGGAACCG-3' (reverse); GAPDH primer, 5'-ATCACCATCTTC CAGGAG-3' (forward) and 5'-ATGGACTGTGGT CATGAG-3' (reverse). A GeneAmp PCR system 9600 (Perkin-Elmer) was programmed for cDNA synthesis and pre-denaturation for 30 min at 50°C and 15 min at 95°C, followed by 22 thermal cycles of 30 s at 94°C, 30 s at 55°C, 30 s at 72°C and a final extension for 10 min at 72°C.
Immunoprecipitation and Western blotting. After the cells had been treated with IL-1β for 12 h, the conditioned medium was isolated. The medium (550 μL) was incubated with protein G-Sepharose 4FF conjugated with normal mouse IgG at 4°C for 1 h. After centrifugation 15,000 g for 10 min, the supernatant was incubated with mouse IgG, or mouse antihuman-uPA (1 μg) or anti-human-tPA (10 μg) antibodies conjugated with protein G-Sepharose 4FF at 4°C overnight. Following this, the supernatant and protein G-Sepharose were separated by centrifugation, and the supernatant was subjected to PA assay. The collected protein G-Sepharose was boiled in sample buffer for SDS-PAGE and used for Western blotting. For Western blotting, proteins on the protein G-Sepharose beads were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with the anti-uPA or anti-tPA antibody (each at 1 μg/mL). An ECL chemiluminescence reaction kit (Amersham Bioscience, UK) was used for detec- Fig. 1 IL-1 -stimulated PA secretion. Human dental pulp cells were stimulated with 100 pg/mL IL-1 ( ) or unstimulated ( ) (A), and were stimulated with various concentrations of IL-1 for 12 h (B). PA activity secreted into the medium was then determined. Results are means ± SE from 4 independent experiments. *p < 0.05, **p < 0.01, significantly different from the control.
less marked.
The signaling pathway of IL-1β-induced uPA expression
We next investigated the signaling systems involved in the induction of uPA mRNA by IL-1β. Because IL-1β-induced responses are well known to be coupled to tyrosine phosphorylation (4, 17, 23, 24) , we examined the contribution of tyrosine phosphorylation to IL-1β-induced uPA mRNA expression. When the cells were incubated in the presence of the tyrosine kinase inhibitors herbimycin A (1 μM) and genistein (50 μM), IL-1β failed to induce any expression of uPA mRNA (Fig. 5A ). In the presence of sodium orthovanadate (100 μM), a tyrosine phosphatase inhibitor, IL-1β-induced uPA mRNA expression appeared to be unchanged or rather enhanced (Fig. 5A) . When the cells were incubated with these inhibitors in the absence of IL-1β, no change in the expression of uPA mRNA was observed (data not shown). These observations suggest that IL-1β induces uPA mRNA expression via tyrosine phosphorylation.
ter the cells had been incubated with IL-1β (100 pg/ mL) for 12 h, the medium was isolated. When the medium was treated with protein G-Sepharose conjugated with anti-uPA antibody and centrifuged, all PA activity in the medium disappeared, as Fig. 2 shows. In contrast, when anti-tPA antibody or normal IgG was used instead of anti-uPA antibody, PA activity remained in the medium. This result suggested that PA was immunoprecipitated with antiuPA antibody. We then examined the presence of uPA on the protein G-Sepharose by Western blotting. As Fig. 3 shows, a 33-kDa protein was detected on the precipitated beads by anti-uPA antibody, and this molecular mass corresponded to that of uPA prepared from human urine. These observations strongly suggest that the PA secreted from IL-1β-stimulated human dental pulp cells is the urokinase type.
IL-1β-induced expression of uPA mRNA
Next, using RT-PCR, we examined the effect of IL-1β on expression of mRNA for uPA and tPA in human dental pulp cells. As Fig. 4 shows, 349-bp and 985-bp bands, corresponding to uPA and tPA mRNAs, respectively, were detected, although the uPA band was much clearer than the tPA band. When the cells were stimulated with IL-1β (100 pg/ mL), expression of uPA mRNA was clearly enhanced by 3 h and then declined. On the other hand, the effect of IL-1β on tPA mRNA expression was Fig. 4 Effect of IL-1 on uPA mRNA expression in human dental pulp cells. Human dental pulp cells were incubated with 100 pg/mL IL-1 for the indicated times. Levels of mRNA for uPA, tPA and glyceraldehyde-3-phophate dehydrogenase (GAPDH) were assessed by RT-PCR. PCR fragments were electrophoresed on 2% agarose gel and subsequently stained with ethidium bromide. Fig. 2 Disappearance of PA activity secreted from IL-1 -stimulated cells by treatment with anti-uPA antibody. The conditioned medium in which human dental pulp cells had been stimulated with IL-1 (100 pg/mL) for 12 h was isolated, and then incubated with protein Sepharose G conjugated with mouse IgG, or anti-human uPA or anti-human tPA antibodies at 4°C overnight. After removing the protein Sepharose by centrifugation, PA activity in the conditioned medium was determined. Values are means ± SE from 4 independent experiments. the cells were stimulated with IL-1β in the presence of sodium orthovanadate (100 μM), uPA activity in the medium was increased (Fig. 6) . The tyrosine kinase and phosphatase inhibitors and the NFκB inhibitor had no effect on uPA activity in the medium with non-stimulated cells (data not shown). Since the effects of the inhibitors on uPA activity expression was consistent with that on uPA mRNA, it is most likely that uPA activity in the medium indicates uPA protein secreted from human dental pulp cells.
DISCUSSION
In this study we demonstrated that the inflammatory cytokine IL-1β stimulated the expression of uPA mRNA and also uPA secretion in human dental pulp cells. The IL-1β-induced expression of uPA mRNA was completely abolished by tyrosine kinase inhibitors, and was further clearly activated by a tyrosine phosphatase inhibitor. These observations suggest that tyrosine phosphorylation is a crucial event in IL-1β-stimulated uPA production, as has been demonstrated for IL-1β-induced cyclooxygenase-2 (4, 23, 24) and inducible nitric oxide synthase expression (17) . Secretion of uPA induced by IL-1β was also inhibited or enhanced in the presence of the tyrosine kinase inhibitors or the tyrosine phosphatase inhibitor, respectively, suggesting that secretion of uPA is coupled to uPA production.
The IL-1β-induced expression of uPA mRNA was also inhibited by the NFκB inhibitor PDTC (8, 21, 22) , suggesting that NFκB plays a role in IL-1β-induced uPA production. NFκB, a transcription factor, regulates the expression of several genes involved in inflammatory responses (1, 18) . In resting cells, NFκB exists in the cytoplasm as a heterodimer consisting of p50, p65 and IκB subunits. Upon stimulation with a variety of inducers such as IL-1β, IκB dissociates from the NFκB complex, allowing it to translocate to the nucleus. Binding of NFκB to the IκB consensus sequences initiates gene transcription. Therefore, it is likely that uPA expression is regulated by NFκB activation in human dental pulp cells.
uPA is thought to be secreted as the inactive form, pro-uPA (13, 27) , which is markedly activated when it binds to its receptors, uPAR (6, 9) . Receptor-bound pro-uPA is cleaved by proteases, such as plasmin, kallikrein, Factor XIIa or cathepsin B, to yield the disulfide linked two-chain active enzyme (7, 14) . It has been reported that expression of uPAR mRNA, along with the increase of uPA mRNA, is NFκB is a critical factor involved in the transcriptional control of several inflammation-related genes. Therefore we investigated the contribution of NFκB to IL-1β-induced uPA mRNA expression in human dental pulp cells. In the presence of the NFκB inhibitor PDTC (50 μM), IL-1β-induced uPA mRNA expression was inhibited (Fig. 5B) . PDTC had no effect on uPA mRNA expression in the cells without IL-1β stimulation (data not shown). These results suggest that IL-1β induces uPA mRNA expression via NFκB activation.
Effects of inhibitors of tyrosine kinase, tyrosine phosphatase and NFκB on uPA secretion from IL-1β-stimulated cells
Next we examined the effects of inhibitors of tyrosine kinase, tyrosine phosphatase and NFκB inhibitors on IL-1β-stimulated uPA secretion in human dental pulp cells. When the cells were stimulated with IL-1β (100 pg/mL) in the presence of herbimycin A (1 μM), genistein (50 μM) or PDTC (50 μM) for 12 h, PA activity in the medium was clearly reduced, as shown in Fig. 6 . On the other hand, when up-regulated by stimulation with inflammatory cytokines such as IL-1β for 4 h, suggesting that uPA plays a role in tissue repair after gastric acute inflammation (10) . We found that IL-1β stimulation for 3-12 h resulted in clear expression of uPA mRNA and secretion of uPA in human dental pulp cells. These observations suggest that the uPA expression induced by IL-1β contributes to inflammation of dental pulp cells at an early stage.
In human dental pulp cells, TNF-α, another cytokine, has been reported to enhance the expression of tPA mRNA, but not that of uPA mRNA (30) . Further studies are needed to clarify differences in effects between IL-1β and TNF-α.
In conclusion, the inflammatory cytokine IL-1β has been shown to stimulate uPA mRNA expression and uPA secretion in human dental pulp cells, and these effects were reduced by inhibitors of tyrosine kinase and NFκB and enhanced by a tyrosine phosphatase inhibitor. These observations suggest that IL-1β-induced uPA secretion is coupled to uPA expression, and may contribute to the early stage of dental pulp inflammation.
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This study was supported in part by Grant-in-Aid for Scientific Research from JSPS (#17592001, stimulated by IL-1β in human gingival fibroblasts and gastric fibroblasts (10, 25) . Therefore, enhancement of uPAR expression appears to be necessary for the function of uPA secreted from human dental pulp cells.
Plasmin production via uPA activation, and proteolytic degradation of the extracellular matrix, are considered to have important roles at different stages of wound healing, such as inflammation, granulation tissue formation, matrix formation and reepithelialization (5) . An immunohistochemical study of periodontal wound healing in a rat model has shown that the plasminogen activator system, including uPA expression, is involved, because the localization of uPA, as well as plasminogen activator inhibitors, changed with the progress of wound healing (32) . Transforming growth factor-β1 (TGF-1β), a key player in connective tissue remodeling and inflammation, has been demonstrated to repress uPA expression in healthy gingival fibroblasts but to promote it in granulation-tissue fibroblasts, which are involved in the response to tissue injury (29) . In such systems, uPA was expressed during days 2-7. In human gingival fibroblasts, stimulation with IL-1β for 10 h resulted in slight uPA expression in inflammatory cells, but failed to stimulate any such expression in healthy cells (31) . On the other hand, expression of uPA mRNA in gastric fibroblasts was 
